Literature DB >> 18432780

Production of mouse T cell hybridomas.

A M Kruisbeek1.   

Abstract

T cell hybridomas can be obtained by fusing activated T cells with tumor cells. A heterogeneous population of hybridomas can be cloned by limiting dilution to obtain hybridomas that express specificity to one T cell receptor (TCR). This unit describes cell fusion and selection of T cell hybridomas. A protocol is provided for screening of T cell hybridomas for expression of the CD3-TCR complex by flow cytometry analysis. Those hybridomas expressing a CD3-TCR complex are then further tested for expression of antigen specificity by screening for specific antigen-induced lymphokine production. The procedures for establishment of stable hybridoma lines and cloning of stable lines by limiting dilution are identical to those described for B cell hybridomas and can be found in UNIT 2.5. Protocols for freezing and thawing T cell hybridomas are identical to those described for B cell hybridomas and other cell lines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18432780     DOI: 10.1002/0471142735.im0314s24

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  9 in total

1.  CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.

Authors:  Katharina N Steinitz; Pauline M van Helden; Brigitte Binder; David C Wraith; Sabine Unterthurner; Corinna Hermann; Maria Schuster; Rafi U Ahmad; Markus Weiller; Christian Lubich; Maurus de la Rosa; Hans Peter Schwarz; Birgit M Reipert
Journal:  Blood       Date:  2012-03-06       Impact factor: 22.113

2.  T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens.

Authors:  Judith N Mandl; João P Monteiro; Nienke Vrisekoop; Ronald N Germain
Journal:  Immunity       Date:  2013-01-03       Impact factor: 31.745

3.  Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.

Authors:  Dongchang Zhao; James S Young; Yu-Hong Chen; Elizabeth Shen; Tangsheng Yi; Ivan Todorov; Peiguo G Chu; Stephen J Forman; Defu Zeng
Journal:  J Immunol       Date:  2010-12-13       Impact factor: 5.422

4.  Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4+ T Cells.

Authors:  Alison J Johnson; Steven C Kennedy; Cecilia S Lindestam Arlehamn; Michael F Goldberg; Neeraj K Saini; Jiayong Xu; Sinu Paul; Subray S Hegde; John S Blanchard; John Chan; William R Jacobs; Alessandro Sette; Steven A Porcelli
Journal:  Infect Immun       Date:  2017-03-23       Impact factor: 3.441

5.  Versatility of using major histocompatibility complex class II dextramers for derivation and characterization of antigen-specific, autoreactive T cell hybridomas.

Authors:  Bharathi Krishnan; Chandirasegaran Massilamany; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Charles Kuszynski; Barbara Switzer; Daniel A Peterson; Jay Reddy
Journal:  J Immunol Methods       Date:  2015-08-09       Impact factor: 2.303

6.  Nature of T cell epitopes in lupus antigens and HLA-DR determines autoantibody initiation and diversification.

Authors:  Zhenhuan Zhao; Jiling Ren; Chao Dai; Carol C Kannapell; Hongyang Wang; Felicia Gaskin; Shu Man Fu
Journal:  Ann Rheum Dis       Date:  2018-09-25       Impact factor: 19.103

7.  Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection.

Authors:  Nicole Torti; Senta M Walton; Thomas Brocker; Thomas Rülicke; Annette Oxenius
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

8.  Antigen-Specific Th17 Cells Are Primed by Distinct and Complementary Dendritic Cell Subsets in Oropharyngeal Candidiasis.

Authors:  Kerstin Trautwein-Weidner; André Gladiator; Florian R Kirchner; Simone Becattini; Thomas Rülicke; Federica Sallusto; Salomé LeibundGut-Landmann
Journal:  PLoS Pathog       Date:  2015-10-02       Impact factor: 6.823

9.  In silico Design of Phl p 6 Variants With Altered Fold-Stability Significantly Impacts Antigen Processing, Immunogenicity and Immune Polarization.

Authors:  Petra Winter; Stefan Stubenvoll; Sandra Scheiblhofer; Isabella A Joubert; Lisa Strasser; Carolin Briganser; Wai Tuck Soh; Florian Hofer; Anna Sophia Kamenik; Valentin Dietrich; Sara Michelini; Josef Laimer; Peter Lackner; Jutta Horejs-Hoeck; Martin Tollinger; Klaus R Liedl; Johann Brandstetter; Christian G Huber; Richard Weiss
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.